Issue 2/2012
Content (17 Articles)
Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
Mizue Terai, Masumi Eto, Garbo D. Young, David Berd, Michael J. Mastrangelo, Yutaka Tamura, Kenichi Harigaya, Takami Sato
Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001
Eleni-Kyriaki Vetsika, Georgios Konsolakis, Despoina Aggouraki, Athanasios Kotsakis, Elisavet Papadimitraki, Soultana Christou, Jeanne Menez-Jamet, Kostas Kosmatopoulos, Vassilis Georgoulias, Dimitris Mavroudis
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients
Ray Wilkinson, Katherine Woods, Rachael D’Rozario, Rebecca Prue, Frank Vari, Melinda Y. Hardy, Ying Dong, Judith A. Clements, Derek N. J. Hart, Kristen J. Radford
Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy
Rieneke van de Ven, Anneke W. Reurs, Pepijn G. J. T. B. Wijnands, Sandra van Wetering, Ada M. Kruisbeek, Erik Hooijberg, George L. Scheffer, Rik J. Scheper, Tanja D. de Gruijl
The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors
Mark-Alexander Schwarzbich, Michael Gutknecht, Julia Salih, Helmut R. Salih, Peter Brossart, Susanne M. Rittig, Frank Grünebach
Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory
Jang-June Park, Sudarshan Anand, Yuming Zhao, Yumiko Matsumura, Yukimi Sakoda, Atsuo Kuramasu, Scott E. Strome, Lieping Chen, Koji Tamada
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
Abhishek D. Garg, Dmitri V. Krysko, Peter Vandenabeele, Patrizia Agostinis
Regulatory dendritic cells in the tumor immunoenvironment
Galina V. Shurin, Camille E. Ouellette, Michael R. Shurin
MicroRNA regulation in cancer-associated fibroblasts
Olga Aprelikova, Jeffrey E. Green
Immunological monitoring of the tumor immunoenvironment for clinical trials
Anatoli M. Malyguine, Susan L. Strobl, Michael R. Shurin
Novel insights into the molecular mechanisms of HLA class I abnormalities
Barbara Seliger
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi, Veronica Huber, Licia Rivoltini
Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split anergy in natural killer cells
Anahid Jewett, Han-Ching Tseng
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
Viktor Umansky, Alexandra Sevko
Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells
Arthur A. Hurwitz, Stephanie K. Watkins
From cell regulation to patient survival: 2nd Cancer immunotherapy and immunomonitoring (CITIM) meeting, Budapest, 2–5 May 2011
Viktor Umansky, Anatoli Malyguine, Beatrix Kotlan, Natalia Aptsiauri, Michael R. Shurin